Equity
€62,755 ▲ 4.3%
BOVISEL has made a profit in every financial year since 2011.
BOVISEL
Lifetime
15 annual accounts with figures on one time axispeak €13,679 (2023)
€7,836▼ 22.9%
peak €7,986 (2015)
€2,612▼ 38.5%
peak €62,755 (2025)
€62,755▲ 4.3%
€10,651▼ 45.5%
Board7 names since 2010
6 directors and 5 others
Documentsfilings and deeds
29-01-20262 days before the deadline
2025micro format
Gross margin from €10,168 to €7,836Result from €4,245 to €2,612Debts from €19,550 to €10,651
Key points
from the 2025 annual accountsTurnover
≈ €82,000 estimated
The micro format states no turnover.
Position in the sector
85.5%
Higher solvency than 91% of companies in retail trade. Sector median 33.1% · 22,939 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 10,902 companies had the same profile as BOVISEL has now. Each dot stands for 28 companies, two years later.
95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 10,902 companies, not a prediction for BOVISEL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 20-01-2023
Director, since 20-01-2023
Director, since 20-01-2023
Director, since 20-01-2023
Manager
Manager
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0826254314
4 directors resigning, 4 reappointments
Resignations: , , and · Reappointments: , , and · Gazette deed
Appointments: (manager) and (manager)
General meeting of 01-06-2019 · Gazette deed
First establishment
Mariënhovestraat 18, Tielt
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BOVISEL Tielt | €73,406 | €7,836 | 85.5% | - |
| Apotheek Stockman Zelzate | €79,309 | €9,633 | -14.8% | - |
| Pharmacie Marievoet Auderghem | €60,288 | €10,806 | 2.7% | - |
| APOTHEEK VERSE Brussels | €98,336 | €6,020 | -65.5% | - |
| BEUKELEIRS HOLDING Vielsalm | €66,647 | €7,251 | 83.3% | - |
| GOED TER LEY Sint-Laureins | €95,515 | €5,055 | 92.8% | - |
| APOTHEEK BRABANTDAM Ghent | €93,195 | €7,971 | 52.5% | - |
These companies have the same main activity as BOVISEL: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €60,300 and €98,300, founded between 2007 and 2017.
Official details
Source: KBO- Status
- Active since 27-05-2010Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 1 other
- Establishment unit
- 2.188.896.0608700 Tielt, since 01-06-2010
- Financial year end
- 30 June
- Peppol
- Reachable since 06-12-2025
Annual accounts to 30-06-2025
- €73,406▼ 7.9%
- Filing
- Filed on 29-01-2026, 2 days before the end of the filing period
Insights on BOVISEL
BOVISEL files the micro format. That format states no turnover. The gross margin rose from €4,226 in 2011 to €7,836 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BOVISEL
- What is the company number of BOVISEL?
- The company number of BOVISEL is 0826.254.314. The VAT number is the same number with BE in front: BE 0826.254.314.
- Where is BOVISEL based?
- The registered office is at Mariënhovestraat 18, 8700 Tielt.Company details
- What does BOVISEL do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of BOVISEL?
- BOVISEL is a private limited company (BV).
- When was BOVISEL founded?
- BOVISEL was founded on 27-05-2010.
- Is BOVISEL still active?
- Yes, BOVISEL is an active enterprise in the KBO register.
- What is the turnover of BOVISEL?
- The turnover in financial year 2025 is ≈ €82,000. This figure is estimated from the gross margin of €7,836 and 118 comparable companies (NACE 477). It probably lies between €30,000 and €170,000. It is a rough estimate. In financial year 2020 turnover was €8,973.Financials
- Is BOVISEL profitable?
- In financial year 2025, BOVISEL made a profit of €2,612.
- Where can I find the annual accounts of BOVISEL?
- BOVISEL filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BOVISEL due?
- BOVISEL must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.